REPORT OUTLOOK
Market Size | CAGR | Dominating Region |
---|---|---|
USD 26 billion | 22% | North America |
by Procedure | by End User | by Region |
---|---|---|
|
|
|
SCOPE OF THE REPORT
Transcatheter Aortic Valve Replacement (TAVR) Market Overview
The global transcatheter aortic valve replacement (TAVR) market is expected to grow at 22% CAGR from 2022 to 2029. It is expected to reach above USD 26 billion by 2029 from USD 4.34 billion in 2020.
Transcatheter aortic valve implantation (TAVI) denotes a procedure involving the insertion of a specialized transcatheter aortic valve to restore the heart’s aortic valve function. This implantation, employing transfemoral, transaortic, and transapical approaches, aims to address severe aortic stenosis. The evolution of TAVI technology has significantly enhanced patient outcomes and broadened its applicability. Innovations in valve designs, delivery systems, and imaging modalities have rendered TAVI procedures safer and more efficient, positioning them as a less invasive alternative to surgical aortic valve replacement (SAVR). The minimally invasive nature of TAVI contributes to shorter hospital stays, faster recovery periods, and diminished post-operative complications, which resonate with patients and healthcare providers alike.
With mounting clinical evidence validating TAVI’s efficacy, there exists an opportunity for expanded reimbursement policies. Broader coverage by healthcare systems and insurers could bolster patient accessibility to TAVI and propel market expansion. While TAVI predominantly serves high-risk or inoperable individuals with severe aortic stenosis, efforts are underway to broaden its indications to encompass intermediate and low-risk patients. Ongoing clinical trials are investigating the safety and effectiveness of TAVI in these patient cohorts, presenting significant potential for market growth.
The regulatory landscape governing the Transcatheter Aortic Valve Replacement (TAVR) market is robust and meticulously structured to safeguard patient welfare and procedural efficacy. Regulatory oversight, spearheaded by entities such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe, entails rigorous requirements encompassing preclinical assessments, clinical trials, and post-market surveillance protocols. Scrutiny extends to manufacturing standards, product labeling, and adverse event monitoring, all aimed at upholding quality benchmarks and mitigating procedural risks associated with TAVI. Compliance with these regulatory mandates is imperative for manufacturers to secure and sustain market authorization for their TAVI offerings.
Transcatheter Aortic Valve Replacement (TAVR) Market Segment Analysis
Transcatheter aortic valve replacement (TAVR) market is distributed by procedure into transfemoral implantation, transapical implantation, transaortic implantation as well as market is classified by end users into hospitals, ambulatory surgical centers, and so on.
The transapical implantation contains antegrade aortic valve implantation with direct access and precise positioning of a stent-based transcatheter xenograft employing an oversizing technique. Femoral arterial and venous access wires, anterolateral mini-thoracotomy, epicardial pacing, and apical purse string suture implantation are all steps in the procedure. During rapid ventricular pacing, valve placement is done under fluoroscopic and echocardiographic supervision.
Transapical implantation segment holds the largest market share because of its ease of use and lower risk of complications than other implantation methods, transapical implantation is expected to be the fastest expanding category during the projection period. This approach allows for easy entry of devices of any diameter, resulting in longer tissue lifetime.
Transcatheter Aortic Valve Replacement (TAVR) Market Players
Healthcare companies to small ones, many companies are actively working in the global transcatheter aortic valve replacement (TAVR) market. These key players include, are CryoLife, Inc., Abbott; Micro Interventional Devices, Inc., Boston Scientific Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., Edwards Lifesciences Corporation, Medtronic, Auto Tissue Berlin GmbH, lepumedical.com, Neovasc Inc., TTK HealthCare and JenaValve Technology, Inc. and others.
Companies are mainly in the life sciences manufacturing and they are competing closely with each other. Innovation is one of the most important and key strategy as it has to be for any transcatheter aortic valve replacement (TAVR) market. However, companies in the market have also opted and successfully driven inorganic growth strategies like mergers & acquisition and so on.
- In 2019, Medtronic has released Evolut PRO+. It is a transcatheter aortic valve replacement (TAVR) system.
- In 2019, Meril Life Sciences has introduced TAVR technology namely MyvalTM -THV system. This company became the first Indian company to market and distribute its indigenously designed and patented TAVR technology, MyvalTM -THV system, to the European Union and other countries.
- In 2019, Boston Scientific’s has approved the FDA regarding LOTUS Edge Aortic Valve System in patients at high risk for surgical valve replacement via open heart surgery.
Who Should Buy? Or Key Stakeholders
- Life sciences manufacturers
- Transcatheter aortic valve replacement (TAVR) suppliers
- Healthcare companies
- Investors
- Manufacturing companies
- End user companies
- Research institutes
- Healthcare
- Others
Key Takeaways
- The global transcatheter aortic valve replacement (TAVR) market is expected to grow at 22% CAGR.
- Based on the implantation procedure, the transfemoral segment dominated the market.
- Based on end-use, hospitals accounted for the largest market share.
- North America shares 48% of total market.
- The major trend in Transcatheter Aortic Valve Replacement (TAVR) is its expanding indications to include intermediate and low-risk patients, driving market growth and accessibility.
Transcatheter Aortic Valve Replacement (TAVR) Market Regional Analysis
The global transcatheter aortic valve replacement (TAVR) market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
Its major share is occupied by North America, Europe and Asia Pacific region. North America shares 48% of total market. After that, Rest Of the world 52% of global market respectively.
Asia-Pacific is contributing a decent revenue share to the oleoresins industry owing to an increase in the occurrences of aortic stenosis disorders, improving healthcare infrastructure, and increased concern of transcatheter aortic valve implantation. Because of its huge population base and a variety of cardiovascular and lifestyle illnesses, Asia-Pacific offers lucrative potential for participants in the transcatheter aortic valve implantation market. Furthermore, the rise in the number of transfemoral TAVI treatments in emerging nations such as India and China are one of the primary drivers of market expansion.
Due to increasing urbanization, technological advancements, and increased expenditures in end-use industries, the US is the leading country in the transcatheter aortic valve replacement (TAVR) market. The transcatheter aortic valve replacement (TAVR) market in India and China has been bolstered by increased demand in the hospitals, ambulatory surgical centers, and others.
Key Market Segments: Global Transcatheter Aortic Valve Replacement (TAVR) Market
Global Transcatheter Aortic Valve Replacement (TAVR) Market by Procedure, 2020-2029, (USD Million)
- Transfemoral Implantation
- Transapical Implantation
- Transaortic Implantation
Global Transcatheter Aortic Valve Replacement (TAVR) Market by End User, 2020-2029, (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Transcatheter Aortic Valve Replacement (TAVR) Market by Region, 2020-2029, (USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East And Africa
Important Countries In All Regions Are Covered.
Key Question Answered
- What are the growth opportunities related to the adoption of transcatheter aortic valve replacement (TAVR) market across major regions in the future?
- What are the new trends and advancements in the transcatheter aortic valve replacement (TAVR) market?
- Which product categories are expected to have highest growth rate in the transcatheter aortic valve replacement (TAVR) market?
- Which are the key factors driving the transcatheter aortic valve replacement (TAVR) market?
- What will the market growth rate, growth momentum or acceleration the market carries during the forecast period?
Table of Content
- Introduction
- Market Definition
- Market Segmentation
- Research Timelines
- Assumptions and Limitations
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject-Matter Experts’ Advice
- Quality Checks
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Sources
- Data Mining
- Executive Summary
- Market Overview
- Global Transcatheter Aortic Valve Replacement (TAVR) Market Outlook
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of Covid-19 On Global Transcatheter Aortic Valve Replacement (TAVR) Market
- Global Transcatheter Aortic Valve Replacement (TAVR) Market Outlook
- Global Transcatheter Aortic Valve Replacement (TAVR) Market by Procedure, (USD Million)
- Transfemoral Implantation
- Transapical Implantation
- Transaortic Implantation
- Global Transcatheter Aortic Valve Replacement (TAVR) Market by End User, (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Others
- Global Transcatheter Aortic Valve Replacement (TAVR) Market by Region, (USD Million)
- Introduction
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- South-East Asia
- Rest of Asia-Pacific
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Rest of Europe
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- Middle- East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle- East and Africa
- Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)
- CryoLife, Inc.
- Abbott
- Micro Interventional Devices, Inc.
- Boston Scientific Corporation
- LivaNova PLC
- Meril Life Sciences Pvt. Ltd.
- Edwards Lifesciences Corporation
- Medtronic
- Auto Tissue Berlin GmbH
- com
- Others *The Company List Is Indicative
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY REGION (USD MILLIONS), 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (MILLIONS), 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY APPLIACTION (USD MILLIONS), 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â UK TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â UK TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â UAE TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â UAE TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE (USD MILLIONS), 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER (USD MILLIONS), 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE, USD MILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER USD MILLION, 2020-2029
FIGURE 10Â Â Â Â Â Â Â Â Â Â GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 11          PORTER’S FIVE FORCES MODEL
FIGURE 12Â Â Â Â Â Â Â Â Â Â GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY PROCEDURE, USD MILLION, 2020-2029
FIGURE 13Â Â Â Â Â Â Â Â Â Â GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY END USER, USD MILLION, 2020-2029
FIGURE 14Â Â Â Â Â Â Â Â Â Â GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 15Â Â Â Â Â Â Â Â Â Â GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET BY REGION 2021
FIGURE 16Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 17Â Â Â Â Â Â Â Â Â Â MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
FIGURE 18Â Â Â Â Â Â Â Â Â Â CRYOLIFE, INC.: COMPANY SNAPSHOT
FIGURE 19Â Â Â Â Â Â Â Â Â Â ABBOTT: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â Â Â Â MICRO INTERVENTIONAL DEVICES, INC.: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â LIVANOVA PLC: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â MEDTRONIC: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â AUTO TISSUE BERLIN GMBH: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â LEPUMEDICAL.COM: COMPANY SNAPSHOT
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.